UNSPSC 51412400: Vasodilator benzopyrans

Vasodilator drugs made from

UNSPSC 51412400 Vasodilator benzopyrans is a Class code encompassing medications used by emergency medical services, hospital systems, and public health agencies in acute-care settings. State and local governments procure these drugs through competitive solicitations for use by fire departments, emergency services, and healthcare systems, typically in small-unit quantities with firm pricing, expiration-date guarantees, and shelf-life warranties. Issuing bodies include municipal purchasing departments, state health agencies, and regional cooperative purchasing alliances. The City of Tampa, Texas Health and Human Services Commission, and Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent the institutional mix—municipal fire rescue, state Medicaid and employee health benefit programs, and multistate cooperative vehicles for shared pharmaceutical procurement across participating jurisdictions and vendors.

Recent activity centers on Florida and Texas, with broader multistate coverage through MMCAP. The City of Tampa's Purchasing Department issued IFB 26P00188 for Advanced Life Support Medications (due April 8, 2026) requesting 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials for Tampa Fire Rescue, with an estimated contract value of $40,000 and a one-year term plus optional renewals; the solicitation included a 5 percent SLBE bid discount not to exceed $10,000. The Texas Health and Human Services Commission released RFI HHS0017013 (due April 3, 2026) seeking vendor capabilities for direct-to-manufacturer pharmacy programs serving state employee and Medicaid populations. MMCAP issued RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, effective July 1, 2026, with a two-year initial term and performance penalties ranging from $200 to $1,500 per violation; vendors must maintain commercial general liability insurance of $5,000,000 per occurrence and comply with cGMP and DSCSA certifications.